Median Technologies (FR0011049824, ALMDT, éligible PEA/PME, “Median” ou “La Société”) annonce aujourd’hui qu’eyonis™ LCS (Lung Cancer Screening), son logiciel dispositif médical mettant à profit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results